Arena Pharmaceuticals Inc.
Rank 7
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
$65.9000
USD
0.61%
Market cap
$3,283,478,175
Total volume
$17,911,158
Shares outstanding
49,825,162
Rank 7
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ARNA |
$17,911,158
|
100% |
$65.9000
|
Chart